Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03723330
Other study ID # S6
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date December 9, 2019
Est. completion date May 31, 2021

Study information

Verified date August 2021
Source National University, Singapore
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of the research is to assess the impact of co-consuming plant sterols-enriched food product as part of a healthy eating pattern diet on endothelial function (brachial artery FMD, vasodilation-related and vasoconstriction-related biomarkers) and blood pressure management (24-hour ambulatory and classic blood pressure) in Singapore individuals with MetS.


Description:

This is a 13-wk double-blinded, randomized, crossover study design. Following a 1-wk pre-intervention baseline period, subjects will be randomly assigned to follow a healthy eating pattern diet either contain 2.0 g free plant sterols equivalent of their palmityl esters (Plant Sterol Diet) or do not contain plant sterols (Control Diet) for 4 weeks. After a 4-week dietary 'washout' period, they will consume the alternative diet for 4 weeks. The random assignment will be done with SAS 9.4 software. Body size measurement, dietary assessment, brachial artery FMD and blood pressure measurements, and fasting-state blood collection will be conducted at week 1, 5, 9, and 13, which correspond to before and during the last 1 week of the two 4-week intervention periods. During study week 1 and weeks 6-9, all subjects will consume their habitual, unrestricted self-chosen diets. During study weeks 2-5 and 10-13, all subject will follow a healthy eating pattern diet, referred to as the "My Healthy Plate" designed by HPB. Each subject's energy requirement will be estimated using sex-specific equations and Recommended Dietary Allowances for healthy Singaporean. One-on-one dietary counselling and written instructions for each subject will be provided by a research dietitian and trained research staff to achieve a healthy eating pattern diet. Compliance with the plant sterols consumption will be promoted by frequent online and in-person contact.


Recruitment information / eligibility

Status Completed
Enrollment 20
Est. completion date May 31, 2021
Est. primary completion date May 31, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 35 Years and older
Eligibility Inclusion Criteria: 1. Ability to give an informed consent; 2. Age>35 years old; 3. Meet any 3 of the 5 following NCEP-ATP III MetS criteria (waist circumference > 90 cm (male), > 80 cm (female); fasting glucose concentration = 100 mg/dL or on medication; triglyceride = 150 mg/dL or on medication; high density lipoprotein cholesterol (HDL) < 40 mg/dL (male), < 50 mg/dL (female); systolic or diastolic blood pressure > 130/80 mmHg or on medication); 4. Weight change < 3kg in the past 3 months; 5. No exercising vigorously over the past 3 months; 6. No allergy to plant sterols; no acute illness; not smoking; 7. No drinking more than 2 alcoholic drinks per day; 8. No pregnant, lactating, or planning pregnancy in the next 6 months. Exclusion Criteria: 1. Unable to give an informed consent; 2. Age<35 years old; 3. Meet less than 3 of following NCEP-ATP III MetS criteria (waist circumference > 90 cm (male), > 80 cm (female); fasting glucose concentration = 100 mg/dL or on medication; triglyceride = 150 mg/dL or on medication; high density lipoprotein cholesterol (HDL) < 40 mg/dL (male), < 50 mg/dL (female); systolic or diastolic blood pressure > 130/80 mmHg or on medication); 4. Weight change > 3kg in the past 3 months; 5. Exercise vigorously over the past 3 months; 6. Allergy to plant sterols; no acute illness; not smoking; 7. Drinking more than 2 alcoholic drinks per day; 8. Pregnant, lactate, or plan pregnancy in the next 6 months.

Study Design


Intervention

Dietary Supplement:
plant sterols
Consumption a healthy eating pattern diet with a plant sterols-enriched food product
Other:
healthy diet
Compliance with a healthy diet in accordance to the recommendation by the Singapore Health Promotion Board.

Locations

Country Name City State
Singapore National University of Singapore Singapore

Sponsors (1)

Lead Sponsor Collaborator
National University, Singapore

Country where clinical trial is conducted

Singapore, 

References & Publications (1)

Ho XL, Loke WM. Dietary Plant Sterols Supplementation Increases In Vivo Nitrite and Nitrate Production in Healthy Adults: A Randomized, Controlled Study. J Food Sci. 2017 Jul;82(7):1750-1756. doi: 10.1111/1750-3841.13752. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Change in brachial artery flow-mediated dilation (FMD) Brachial artery FMD will be measured by high-frequency and ultrasonographic imaging. Every 4 weeks (Week 1, week 5, week 9, week 13)
Primary Change in vasodilation and vasoconstriction related biomarkers Vasodilation and vasoconstriction related biomarkers contains nitric oxide, endothelial nitric oxide synthase, and endothelin-1. They will be measured using the commercially available ELISA assay kits. Every 4 weeks (Week 1, week 5, week 9, week 13)
Primary Change in blood pressure Classical and 24-hour ambulatory blood pressure: Systolic and diastolic blood pressure and 5-day of 24-hour ambulatory blood pressure will be measured. Every 4 weeks (Week 1, week 5, week 9, week 13)
Secondary Change in blood lipid-lipoproteins Assessing the blood lipid-lipoproteins profile includes the measurements of plasma total cholesterol, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, and triglyceride concentrations. Every 4 weeks (Week 1, week 5, week 9, week 13)
Secondary Change in skin carotenoid status Measured using resonance Raman spectroscopy. Every 4 weeks (Week 1, week 5, week 9, week 13)
Secondary Height Height (cm) Pre-intervention only
Secondary Change in weight Weight (kg) Every 4 weeks (Week 1, week 5, week 9, week 13)
Secondary Change in waist circumference Waist circumference (cm) Every 4 weeks (Week 1, week 5, week 9, week 13)
Secondary Change in diet Dietary assessment, 3-day food record Every 4 weeks (Week 1, week 5, week 9, week 13)
Secondary Change in sleep quality (Pittsburgh sleep quality index questionnaire (PSQI)) Recall based questionnaire assessing sleep habits for the past one month only which includes sleeping timing habits and quality of sleep (Very good, Fairly good, Fairly bad and very bad) Every 4 weeks (Week 1, week 5, week 9, week 13)
See also
  Status Clinical Trial Phase
Recruiting NCT05654272 - Development of CIRC Technologies
Recruiting NCT05650307 - CV Imaging of Metabolic Interventions
Recruiting NCT04515303 - Digital Intervention Participation in DASH
Completed NCT04056208 - Pistachios Blood Sugar Control, Heart and Gut Health Phase 2
Recruiting NCT04417387 - The Genetics and Vascular Health Check Study (GENVASC) Aims to Help Determine Whether Gathering Genetic Information Can Improve the Prediction of Risk of Coronary Artery Disease (CAD)
Not yet recruiting NCT06032572 - Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE) N/A
Recruiting NCT04514445 - The BRAVE Study- The Identification of Genetic Variants Associated With Bicuspid Aortic Valve Using a Combination of Case-control and Family-based Approaches.
Enrolling by invitation NCT04253054 - Chinese Multi-provincial Cohort Study-Beijing Project
Completed NCT03273972 - INvestigating the Lowest Threshold of Vascular bENefits From LDL Lowering With a PCSK9 InhibiTor in healthY Volunteers N/A
Completed NCT03680638 - The Effect of Antioxidants on Skin Blood Flow During Local Heating Phase 1
Recruiting NCT04843891 - Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis. Phase 1
Completed NCT04083872 - Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of Highdose CKD-385 in Healthy Volunteers(Fasting) Phase 1
Completed NCT04083846 - Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of High-dose CKD-385 in Healthy Volunteers(Fed) Phase 1
Completed NCT03619148 - The Incidence of Respiratory Symptoms Associated With the Use of HFNO N/A
Completed NCT03693365 - Fluid Responsiveness Tested by the Effective Pulmonary Blood Flow During a Positive End-expiratory Trial
Completed NCT03466333 - Postnatal Enalapril to Improve Cardiovascular fUnction Following Preterm Pre-eclampsia Phase 2
Completed NCT04082585 - Total Health Improvement Program Research Project
Completed NCT05132998 - Impact of a Comprehensive Cardiac Rehabilitation Program Framework Among High Cardiovascular Risk Cancer Survivors N/A
Completed NCT05067114 - Solutions for Atrial Fibrillation Edvocacy (SAFE)
Completed NCT04098172 - Evaluate the Performance and Safety of Comet Pressure Guidewire in the Measurement of FFR N/A